Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)

Publisher： Karger

E-ISSN： 1423-0224|56|2-3|73-85

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.56, Iss.2-3, 2007-11, pp. : 73-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repeated Cortisol Awakening Response as Predictor of Antidepressant Treatment Outcome with Duloxetine

By  

Neuropsychobiology, Vol. 71, Iss. 2, 2015-04 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

On the Pharmacotherapy of Sleep Bruxism: Placebo-Controlled Polysomnographic and Psychometric Studies with Clonazepam

By  

Neuropsychobiology, Vol. 51, Iss. 4, 2005-06 ,pp. : 214-225

Karger

Access to resources Recommend Favorite

Antidepressant Treatment and Dehydroepiandrosterone Sulfate: Different Effects of Amitriptyline and Paroxetine

By  

Neuropsychobiology, Vol. 50, Iss. 3, 2004-09 ,pp. : 252-256

Karger

Access to resources Recommend Favorite

First Experiences in Combination Therapy Using Olanzapine with SSRIs (Citalopram, Paroxetine) in Delusional Depression

By  

Neuropsychobiology, Vol. 43, Iss. 3, 2001-03 ,pp. : 170-174

Karger

Access to resources Recommend Favorite

Association between Serotonin Transporter-Linked Polymorphic Region and Escitalopram Antidepressant Treatment Response in Korean Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 66, Iss. 4, 2012-10 ,pp. : 221-229

Karger

Access to resources Recommend Favorite